Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Surgical Research|December 5, 2020
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a StudiesSalvatore Paiella, Luca Casetti, Jacques Ewald, et al.
The American Journal of Pathology|March 14, 2015
Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinomaPauline Duconseil, Marine Gilabert, Odile Gayet, et al.
Journal of Clinical Medicine|August 14, 2025
Incidence and Predictive Factors of Acute Kidney Injury After Major Hepatectomy: Implications for Patient Management in Era of Enhanced Recovery After Surgery (ERAS) ProtocolsHenri Mingaud, Jean Manuel de Guibert, Jonathan Garnier, et al.
Cancers|July 12, 2025
Splenectomy in Onco-Hematologic Patients: A Retrospective Study of Early Complications and 1-Year MortalityMarion Faucher, Stanislas Ravot, Loïc Barthes, et al.
Oncotarget|December 8, 2014
A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitorOdile Gayet, Celine Loncle, Pauline Duconseil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II TrialMaximiliano Gelli, Jacques Ewald, Marie-Laure Tanguy, et al.
Shock (Augusta, Ga.)|November 29, 2022
LATE POSTPANCREATICODUODENECTOMY HEMORRHAGE: INCIDENCE, RISK FACTORS, MANAGEMENT AND OUTCOMEMathieu Jacquemin, Djamel Mokart, Marion Faucher, et al.
Annals of Surgery|April 16, 2025
Carbohydrate Antigen 19-9 Delta Function for Survival Prediction in Borderline Pancreatic Cancer. A PANC-PALS Consortium International Multicenter Derivation and Validation StudyJonathan Garnier, Alessio Marchetti, Brady Campbell, et al.
Cell Reports|November 30, 2017
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived XenograftsRémy Nicolle, Yuna Blum, Laetitia Marisa, et al.
Frontiers in Medicine|January 11, 2021
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational StudyStefano Partelli, John K Ramage, Sara Massironi, et al.
Pageof 8